European Medicines Agency Adopts Policy on Publication of Clinical Data for Medicinal Products
October 2014Focus on Regulation - Hogan Lovells Blog
On 2 October 2014, the European Medicines Agency (EMA) adopted its long awaited policy on the publication of clinical data for medicinal products (the Policy). Under the Policy, the EMA will proactively publish on its website clinical data submitted as part of an application for marketing authorization for medicinal products through the centralized procedure. The clinical data shall be published following completion of the decision-making process.
To read the full article please click here.